BANNER THUNDERBIRD MEDICAL CENTER
1. Target Overview & Investment Thesis
BANNER THUNDERBIRD MEDICAL CENTER is a 539-bed safety-net/medicaid heavy in MARICOPA, AZ with $674.4M in net patient revenue and a 8.4% operating margin. The hospital serves a payer mix of 13.9% Medicare, 36.7% Medicaid, and 49.3% commercial.
Thesis: Platform Growth. Our ML models identify $49.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.4% to 15.8% (+736bps).
| Net Revenue HCRIS | $674.4M |
| Current EBITDA COMPUTED | $57.0M |
| Operating Margin COMPUTED | 8.4% |
| Occupancy HCRIS | 64.7% |
| Revenue / Bed COMPUTED | $1.3M |
| Net-to-Gross HCRIS | 23.3% |
| Distress Probability ML | 52.9% |
2. Market Context & Competitive Position
AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 8.4% places it above the state median. Among 19 size-comparable peers (270-1078 beds), the median margin is -1.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (270-1078), prioritizing same-state peers. 19 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BANNER THUNDERBIRD MEDICAL CEN (Target) | AZ | 539 | $674.4M | 8.4% |
| MAYO CLINIC HOSPITAL | AZ | 315 | $2.25B | 1.4% |
| BANNER ESTRELLA MEDICAL CENTER | AZ | 317 | $1.84B | 79.2% |
| BANNER BAYWOOD MEDICAL CENTER | AZ | 323 | $1.39B | 79.1% |
| ST. JOSEPHS HOSPITAL & MEDICAL | AZ | 515 | $1.31B | -17.7% |
| PHOENIX CHILDRENS HOSPITAL | AZ | 352 | $1.26B | 6.0% |
| BANNER UNIVERSITY MEDICAL CENT | AZ | 656 | $1.09B | -5.9% |
| BANNER UNIVERSITY MED CENTER T | AZ | 533 | $1.03B | -4.6% |
| BANNER DESERT MEDICAL CENTER | AZ | 629 | $833.1M | 12.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $49.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $14.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $13.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $13.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $8.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $432K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $57.0M |
| + RCM Uplift | +$49.6M |
| Pro Forma EBITDA | $106.6M |
| Current Margin | 8.4% |
| Pro Forma Margin | 15.8% |
| WC Released (1x) | $25.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $87.6M | $872.1M | 9.95x | 58.3% |
| Base (11x exit) | 10.0x | 11.0x | $87.6M | $987.8M | 11.27x | 62.3% |
| Bull Case | 9.0x | 11.0x | $78.9M | $1.18B | 14.96x | 71.8% |
| Bull (12x exit) | 9.0x | 12.0x | $78.9M | $1.31B | 16.62x | 75.4% |
| Bear Case | 11.0x | 10.0x | $96.4M | $595.4M | 6.18x | 43.9% |
| Bear (11x exit) | 11.0x | 11.0x | $96.4M | $686.3M | 7.12x | 48.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (36.7%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 52.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 19 hospitals with 270-1078 beds
- Same-state prioritization (n=20)
- Comp margins: P25=-5.2% / P50=-1.4% / P75=6.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.